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Abstract
The editorial by Jeremy Shiffman, “Knowledge, moral claims and the exercise of power in global health”, highlights 
the influence on global health priority-setting of individuals and organizations that do not have a formal political 
mandate. This sheds light on the way key functions in global health depend on private funding, particularly from 
the Bill & Melinda Gates Foundation.
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In his November editorial “Knowledge, moral claims and the exercise of power in global health”, Jeremy Shiffman (1) draws back the curtain on how global health priorities 
are set. Rather than focusing solely on how aid agencies 
and others with financial resources drive decisions about 
what health conditions warrant increased attention and 
spending, Shiffman looks at individuals and organizations 
that influence debates through other means. In particular, he 
draws attention to the way the Institute for Health Metrics 
and Evaluation (IHME) and the Lancet claim a prominent 
place in discourse about global health priority-setting, basing 
their legitimacy on dominion over data and analysis. He also 
highlights how the definition of the Sustainable Development 
Goals (SDGs), the successor to the Millennium Development 
Goals (MDGs), reflects the influence of many advocates and 
other unofficial actors operating through an opaque process.
Shiffman is right in his observations about the influence of 
individuals and organizations that have no political mandate, 
and exercise power in ways that do not depend on an 
ability to direct funding to particular priorities. IHME, the 
Lancet and other influential actors derive their power from 
a combination of mastery over data and methods, a role in 
arbitrating scientific quality and salience, and an ability to 
advocate both publicly and behind the scenes. In recent years, 
these actors have demonstrated an impressive ability to set 
the global health agenda, and have established themselves 
as central figures in holding donor agencies and others to 
account for responding to that agenda.
But do these influential actors, which are privately supported, 
in fact have power that is independent of their major 
funders? Without private funding they would be unable to 
operate; and one large private funder, the Bill & Melinda Gates 
Foundation, has taken a particularly active role in providing 
support. We need to ask: is it healthy for global health to be 
so strongly influenced by organizations, including funders, 
that are outside of any intergovernmental framework and not 
subject to public accountability? 
Let’s start with one example: Estimates of the Global Burden 
of Disease (GBD) are valuable to the global health community 
in many ways. While hampered by low-quality data on causes 
of death and disability, and dependent on strong assumptions, 
GBD estimates are currently our best way to understand the 
distribution of ill health and premature death across ages 
and regions, and between men and women (2). Almost all 
claims about the relative importance of one disease or health 
condition over another – such as, for example, the recent 
high-level statements about the rapidly growing toll of non-
communicable disease (3) – are based on the GBD estimates. 
In addition, GBD estimates have been used to track and assess 
collective progress toward global goals, such as the reduction 
in maternal mortality (4).
Originally, GBD estimates were developed under the auspices 
of global organizations that have an official mandate to 
generate information and develop policy prescriptions in 
the health field – namely, the World Bank and the World 
Health Organization (WHO) (5). These organizations, for 
all their well-known shortcomings, exist within the official 
architecture of the UN family. They have a formal governance 
structure with appointed and elected representatives, and 
they have diversified funding from public and private sources. 
Since the establishment of the IHME in June 2007 with a 
105 million US dollars grant from the Bill & Melinda Gates 
Foundation (6), the GBD estimates have been prepared and 
published by IHME. The effort is led by Dr. Chris Murray, 
who originally developed the GBD methods. With Gates 
Foundation support, IHME prepared the most recent 
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estimates of the GBD (7), and that information has been used 
by bilateral donors and public policy analysts to inform the 
allocation of resources. As a complementary effort, IHME 
also analyzes trends in donor spending on health, comparing 
it to the distribution of disease burden – information that is 
often cited in official documents (8). As Shiffman indicated, 
IHME has significant influence over priority-setting – and 
that influence is made possible by grants from one private 
funder. 
IHME is hardly the only influential actor in global health 
that benefits from private support. The Lancet, while it 
has diversified funding, is also able to operate as it does 
in part because of support from the Gates Foundation, 
the Rockefeller Foundation and other philanthropic 
sources. Since 2005, the Gates Foundation has supported 
at least five special issues of the Lancet, covering topics 
that included neonatal health, HIV, nutrition and early 
childhood development; in addition, the Gates Foundation 
has supported a Lancet commission on “Investing in Health: 
World Bank World Development Report 1993 at 20 years” (9). 
The Rockefeller Foundation supported a special issue of the 
Lancet on universal healthcare. While these and other funders 
may simply be supporting an existing intellectual agenda, the 
potential for influence with the offer or withdrawal of funding 
must be recognized.
Beyond the generation of reference information and support 
for high-impact journals, philanthropic funding permits 
groups pursuing particular interests to have a prominent role 
in setting global health priorities. Private funding has turned 
global health policy advocacy into a major enterprise within 
the development community. 
For the Gates Foundation, advocacy in support of a 
specific set of global health priorities, such as childhood 
immunization, is an explicit aim and has led to an increase 
in the number, size and influence of many organizations that 
educate the public and policy-makers about global health 
needs and progress, and promote greater spending on a set of 
global health interventions. As the Gates Foundation website 
states: “Because our resources alone are not enough to advance 
the causes we care about, we engage in advocacy efforts to 
promote public policies that advance our work, build strategic 
alliances with governments and the public and private sectors, 
and foster greater public awareness of urgent global issues. 
Our Global Policy & Advocacy Program has teams dedicated 
to advocacy, policy analysis, and government relations, as well 
as strengthening philanthropic partnerships and the charitable 
sector in the United States and overseas” (10). 
Since 2010, for example, the Gates Foundation has provided 
approximately 75 million US dollars to the United Nations 
Foundation, an organization that has significant capacity to 
reach and influence UN agencies and the governments of 
wealthy countries. One of the largest grants, for instance, is 
intended “to raise awareness of and mobilize resources in 
support of MDGs 4, 5 and 6”. Private funding is also being 
directed at influencing the next international development 
goals. Just last month, the Gates Foundation awarded a grant 
to the University of California-San Francisco “to promote 
adoption of  “a grand convergence in global health” as the 
SDG for the health sector, through modeling the health 
outcomes that could be achieved by 2030, developing a 
roadmap for implementation of the convergence agenda, and 
conducting targeted advocacy and policy outreach” (11).
The Gates Foundation is not alone, although it is unique 
in size, scope and ambition. The Rockefeller Foundation, 
the David and Lucile Packard Foundation, the William 
and Flora Hewlett Foundation and other large U.S. private 
philanthropies have supported the work of organizations 
that advocate for an increase in donor spending on specific 
global health programs, and/or a particular geographic or 
substantive orientation. 
None of this is ill-intentioned, and the results can be positive: 
fast uptake of new information by the policy community, 
greater spending on some of the health conditions that affect 
the poorest and the interventions that have the greatest 
potential for good. And increasingly many foundations are 
providing basic information about their grant making, which 
permits some level of scrutiny if not true accountability (12). 
But there is something awry in the global health system 
when so many key functions depend on private support – 
potentially subject to the priorities of a few unofficial actors 
– and policies can be swayed by an army of advocates.
The risks of over-dependence within the global health 
community on a small number of private funders, and 
particularly on the Gates Foundation, can only be mitigated 
through a set of intentional actions in two domains: First, 
bilateral and multilateral agencies have to ensure that they 
have the technical strength to undertake independent, 
unbiased analysis so that they are not overly reliant on 
privately-funded agenda-setting data collection and research. 
Second, the philanthropic sector has to commit to high 
levels of transparency and pluralism, restraining impulses 
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